Overview
Mael Heiblig practices practicing medicine in Pierre-la-treiche, France.
Mr. Heiblig is highly rated in 8 conditions, according to our data. His clinical expertise encompasses VEXAS Syndrome, Acute Myeloid Leukemia (AML), Leukemia, Myelodysplastic Syndrome (MDS), and Bone Marrow Transplant.
He is actively involved in clinical research, co-authoring 113 peer reviewed articles.
Gender
Locations
Valence, France
Lille, France
Amiens, France
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Mael Heiblig
Is Mael Heiblig a top-rated expert for VEXAS Syndrome?
MediFind is an objective health platform that identifies experts based on real-world data. Mael Heiblig is classified as an Elite expert for VEXAS Syndrome, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Mael Heiblig participate in research or clinical trials?
Yes. Mael Heiblig has published 113 articles and abstracts on conditions like VEXAS Syndrome. You can view a list of Mael Heiblig's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- VEXAS SyndromeMr. Heiblig isElite. Learn about VEXAS Syndrome.
- Distinguished
- Acute Myeloid Leukemia (AML)Mr. Heiblig isDistinguished. Learn about Acute Myeloid Leukemia (AML).
- LeukemiaMr. Heiblig isDistinguished. Learn about Leukemia.
- Myelodysplastic Syndrome (MDS)Mr. Heiblig isDistinguished. Learn about Myelodysplastic Syndrome (MDS).
- Advanced
- Acute Promyelocytic LeukemiaMr. Heiblig isAdvanced. Learn about Acute Promyelocytic Leukemia.
- Chronic Myelogenous Leukemia (CML)Mr. Heiblig isAdvanced. Learn about Chronic Myelogenous Leukemia (CML).
- Mast Cell Activation Syndrome (MCAS)
- Systemic MastocytosisMr. Heiblig isAdvanced. Learn about Systemic Mastocytosis.
- Experienced
- Acute Erythroid Leukemia (AEL)Mr. Heiblig isExperienced. Learn about Acute Erythroid Leukemia (AEL).
- Acute Lymphoblastic Leukemia (ALL)Mr. Heiblig isExperienced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Bone Marrow TransplantMr. Heiblig isExperienced. Learn about Bone Marrow Transplant.
- Chronic Myelomonocytic Leukemia (CMML)Mr. Heiblig isExperienced. Learn about Chronic Myelomonocytic Leukemia (CMML).
- Cutaneous Lupus Erythematosus (CLE)Mr. Heiblig isExperienced. Learn about Cutaneous Lupus Erythematosus (CLE).
- Discoid Lupus Erythematosus (DLE)Mr. Heiblig isExperienced. Learn about Discoid Lupus Erythematosus (DLE).
- Enlarged LiverMr. Heiblig isExperienced. Learn about Enlarged Liver.
- Giant Cell Arteritis (GCA)Mr. Heiblig isExperienced. Learn about Giant Cell Arteritis (GCA).
- Hypereosinophilic SyndromeMr. Heiblig isExperienced. Learn about Hypereosinophilic Syndrome.
- Juvenile Temporal ArteritisMr. Heiblig isExperienced. Learn about Juvenile Temporal Arteritis.
- Monoclonal Gammopathy of Undetermined Significance (MGUS)
- Pyoderma GangrenosumMr. Heiblig isExperienced. Learn about Pyoderma Gangrenosum.
- Temporal ArteritisMr. Heiblig isExperienced. Learn about Temporal Arteritis.